During the past decade, Azienda ospedaliera di Rilievo Nazionale "A. Cardarelli" conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 36 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 24 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda ospedaliera di Rilievo Nazionale "A. Cardarelli"" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 17 trials, followed by "Celgene" with 8 trials sponsored, "Hoffmann-La Roche" with 8 trials sponsored, "National Cancer Institute, Naples" with 8 trials sponsored and "Agios Pharmaceuticals, Inc." with 8 trials sponsored. Other sponsors include 68 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda ospedaliera di Rilievo Nazionale "A. Cardarelli"" #1 collaborator was "Clinical Research Technology S.r.l." with 4 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 3 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "University of Campania "Luigi Vanvitelli"" with 3 trials as a collaborator and "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Azienda ospedaliera di Rilievo Nazionale "A. Cardarelli"" are "Leukemia" (11 trials), "Metastatic Breast Cancer" (5 trials), "Acute Lymphoblastic Leukemia" (4 trials), "Acute Myeloid Leukemia" (4 trials) and "Breast Cancer" (4 trials). Many other conditions were trialed in "Azienda ospedaliera di Rilievo Nazionale "A. Cardarelli"" in a lesser frequency.

Most popular intervention types in "Azienda ospedaliera di Rilievo Nazionale "A. Cardarelli"" are "Drug" (86 trials), "Other" (16 trials), "Procedure" (13 trials), "Device" (5 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "cytarabine" (5 trials), "idarubicin" (5 trials), "methotrexate" (5 trials) and "Paclitaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Azienda ospedaliera di Rilievo Nazionale "A. Cardarelli"" are 110 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Azienda ospedaliera di Rilievo Nazionale "A. Cardarelli"". undefined are not yet recruiting, 14 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in Azienda ospedaliera di Rilievo Nazionale "A. Cardarelli", undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda ospedaliera di Rilievo Nazionale "A. Cardarelli", 1 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 5 trials that are defined as “Not Applicable".

Azienda ospedaliera di Rilievo Nazionale "A. Cardarelli" has several departments that took part in Clinical trials: "Aorn Cardarelli - U.O. Cardiologia Con Utic" - 4 trials